Skip to content
Screener

Bruker BRKR Total Liabilities & Equity

Total Liabilities & Equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$113.17B+11.8%
Danaher logo
DanaherDHR
$92.37B+13.2%
TEC
Bio-TechneTECH
$2.55B-3.5%
WAT
Waters CorporationWAT
$24.75B+425%
Agilent Technologies logo
Agilent TechnologiesA
$13.07B+7.5%
908 Devices logo
908 DevicesMASS
$186.7M-4.8%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemJune 30,2026December 31,2025
Current portion of deferred revenue and customer advances444.6441.3
Other current liabilities549.8605.4
Total current liabilities1,204.71,279.2
Long-term debt1,814.71,852.5
Other long-term liabilities597.7599.4
Redeemable noncontrolling interests35.636.8
Total shareholders’ equity2,400.22,473.5
Total liabilities, redeemable noncontrolling interests and shareholders’ equity$6,052.9$6,241.4

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's total liabilities & equity?
Bruker (BRKR) reported total liabilities & equity of $6.05B in Q2 2026.
How has Bruker's total liabilities & equity changed year-over-year?
Bruker's total liabilities & equity decreased by 4.5% year-over-year, from $6.34B to $6.05B.
What is the long-term trend for Bruker's total liabilities & equity?
Over 5 years (2020 to 2025), Bruker's total liabilities & equity has grown at a 15.4% compound annual growth rate (CAGR), from $3.05B to $6.24B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Bruker's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude